Johnson & Johnson - 48 Year Stock Price History | JNJ
Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Johnson & Johnson as of November 19, 2018 is 147.73.
| Johnson & Johnson Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2018 |
131.8115 |
137.3325 |
147.7300 |
119.4000 |
147.7300 |
7.19% |
| 2017 |
126.3827 |
111.3861 |
140.9426 |
107.4630 |
137.8159 |
24.40% |
| 2016 |
107.7696 |
93.9666 |
118.9545 |
89.5432 |
110.7803 |
15.32% |
| 2015 |
91.8875 |
94.9164 |
98.4274 |
84.2322 |
96.0614 |
1.16% |
| 2014 |
90.3412 |
80.4371 |
98.5488 |
76.5403 |
94.9618 |
17.34% |
| 2013 |
74.6987 |
60.7557 |
84.5019 |
60.6699 |
80.9320 |
34.62% |
| 2012 |
56.3714 |
54.4963 |
61.6558 |
52.0551 |
60.1210 |
10.83% |
| 2011 |
51.6024 |
50.1393 |
55.1766 |
46.4376 |
54.2481 |
9.89% |
| 2010 |
48.7009 |
49.8624 |
51.2940 |
44.7000 |
49.3651 |
-0.58% |
| 2009 |
43.8430 |
45.2341 |
50.0782 |
35.0478 |
49.6542 |
11.28% |
| 2008 |
47.7000 |
47.8080 |
53.4419 |
41.2663 |
44.6225 |
-7.77% |
| 2007 |
45.8017 |
46.9642 |
49.6142 |
42.6856 |
48.3811 |
3.61% |
| 2006 |
43.4829 |
42.5847 |
48.5971 |
39.2473 |
46.6954 |
12.44% |
| 2005 |
44.2426 |
42.6180 |
47.2233 |
41.4861 |
41.5275 |
-3.36% |
| 2004 |
37.5193 |
34.3305 |
43.2007 |
33.0397 |
42.9704 |
25.17% |
| 2003 |
34.6389 |
36.1299 |
38.4640 |
32.2350 |
34.3305 |
-2.11% |
| 2002 |
37.3734 |
37.8140 |
42.3206 |
27.1343 |
35.0721 |
-7.88% |
| 2001 |
33.2494 |
32.4199 |
39.2763 |
26.5503 |
38.0717 |
13.97% |
| 2000 |
28.2393 |
28.9587 |
33.4052 |
21.5950 |
33.4052 |
14.04% |
| 1999 |
29.3805 |
25.6768 |
33.3281 |
23.9100 |
29.2916 |
12.46% |
| 1998 |
23.1572 |
19.9418 |
27.6362 |
19.6169 |
26.0464 |
28.99% |
| 1997 |
18.1618 |
15.0349 |
20.5181 |
15.0349 |
20.1932 |
34.31% |
| 1996 |
14.5586 |
12.5435 |
16.2437 |
12.5435 |
15.0349 |
18.11% |
| 1995 |
10.1651 |
7.9623 |
13.6229 |
7.8527 |
12.7296 |
59.14% |
| 1994 |
6.6788 |
6.4521 |
8.1274 |
5.2728 |
7.9988 |
24.99% |
| 1993 |
5.9153 |
6.8878 |
6.8878 |
5.0498 |
6.3993 |
-8.93% |
| 1992 |
6.8059 |
7.6703 |
7.9525 |
5.9455 |
7.0270 |
-10.19% |
| 1991 |
6.0772 |
4.7019 |
7.8924 |
4.4077 |
7.8240 |
62.34% |
| 1990 |
4.1803 |
3.9389 |
4.8795 |
3.4206 |
4.8195 |
23.39% |
| 1989 |
3.2588 |
2.6902 |
3.9060 |
2.6902 |
3.9060 |
42.63% |
| 1988 |
2.5731 |
2.4520 |
2.8176 |
2.2085 |
2.7385 |
16.52% |
| 1987 |
2.6859 |
2.0842 |
3.2662 |
2.0136 |
2.3503 |
15.80% |
| 1986 |
1.9514 |
1.5705 |
2.2735 |
1.4455 |
2.0297 |
27.42% |
| 1985 |
1.3307 |
1.0483 |
1.6574 |
1.0336 |
1.5929 |
49.85% |
| 1984 |
0.9908 |
1.1622 |
1.2048 |
0.8167 |
1.0630 |
-8.54% |
| 1983 |
1.2823 |
1.3746 |
1.4206 |
1.1158 |
1.1622 |
-15.66% |
| 1982 |
1.1216 |
0.9927 |
1.4163 |
0.8862 |
1.3780 |
36.94% |
| 1981 |
0.9141 |
0.8797 |
1.0296 |
0.7676 |
1.0063 |
14.55% |
| 1980 |
0.6898 |
0.6574 |
0.8807 |
0.5736 |
0.8785 |
29.40% |
| 1979 |
0.6091 |
0.6186 |
0.6853 |
0.5507 |
0.6789 |
10.50% |
| 1978 |
0.6329 |
0.6112 |
0.7352 |
0.5402 |
0.6144 |
-1.77% |
| 1977 |
0.5678 |
0.6238 |
0.6255 |
0.5028 |
0.6255 |
0.43% |
| 1976 |
0.6852 |
0.7109 |
0.7593 |
0.5749 |
0.6228 |
-12.03% |
| 1975 |
0.6987 |
0.6487 |
0.7775 |
0.5764 |
0.7080 |
12.01% |
| 1974 |
0.7668 |
0.8666 |
0.9246 |
0.5857 |
0.6321 |
-27.70% |
| 1973 |
0.9198 |
0.9920 |
1.0075 |
0.8104 |
0.8743 |
-13.22% |
| 1972 |
0.9089 |
0.7518 |
1.0192 |
0.7296 |
1.0075 |
32.99% |
| 1971 |
0.6532 |
0.4380 |
0.7605 |
0.4380 |
0.7576 |
73.72% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$391.677B |
$76.450B |
|
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
|
